Skip to content

Clinical Effort Against Smoke Exposure in Cystic Fibrosis

Clinical Effort Against Smoke Exposure in Cystic Fibrosis (CEASE-CF)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04777344
Acronym
CEASE-CF
Enrollment
36
Registered
2021-03-02
Start date
2021-07-08
Completion date
2022-09-27
Last updated
2022-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis

Keywords

caregivers, tobacco, smoke exposure

Brief summary

The study will test the feasibility, acceptability, and preliminary efficacy of a multi-component smoking cessation intervention tailored to the needs of caregivers of children with CF and delivered in clinical settings as part of routine CF care. The ultimate goal of this effort is to reduce the exposure of children and adolescents with CF to tobacco smoke.

Detailed description

This is a single-center, randomized, open-label study to test the feasibility and acceptability (primary outcomes) and preliminary efficacy (secondary outcome) of a multi-component smoking-cessation intervention delivered by a tobacco treatment specialist (TTS) integrated in the multidisciplinary CF care team. The intervention will be tested in a two-group design with a 2:1 allocation. Participants (dyads of caregiver/CF child) will be randomized to either intervention or control group. The intervention group (N=24) will receive the multi-component intervention (intake assessment, follow-up, help with obtaining nicotine replacement therapy, and CF-specific smoke exposure education). The control group (N=12) will receive usual care plus CF-specific smoke exposure education.

Interventions

BEHAVIORALTobacco Treatment Specialist (TTS) intervention

A trained Tobacco Treatment specialist (TTS) embedded in the multi-disciplinary CF care team will provide tobacco use counseling to smoking caregivers of children with CF.

Sponsors

Cystic Fibrosis Foundation
CollaboratorOTHER
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

single-center, randomized, open-label study

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult familial caregiver of a child with CF aged \<18 years * Speak English * Report smoking at least 1 cigarette in the previous week * Not enrolled in a smoking cessation program

Exclusion criteria

* Do not report smoking at least 1 cigarette in the previous week * Currently enrolled in a smoking cessation program.

Design outcomes

Primary

MeasureTime frameDescription
Intervention feasibility6 monthsParticipant drop-out rates and time added to the clinical encounter
Intervention acceptability6 monthsProportion of caregivers who accepted participation; Participant and provider satisfaction with the intervention on a 1-5 Likert scale; Perceived effectiveness of the intervention on a 1-5 Likert scale

Secondary

MeasureTime frameDescription
Self-reported caregiver cessation6 months7-day point prevalence of abstinence measured at 1, 3, and 6 months; Number of cigarettes smoked in the past 7 days, measured at 1, 3, and 6 months
Child smoke exposure6 monthsBiochemically verified with a hair nicotine sample at baseline, 3 months, and 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026